Literature DB >> 31183778

Including positive lymph node count in the AJCC N staging may be a better predictor of the prognosis of NSCLC patients, especially stage III patients: a large population-based study.

Yanling Fan1, Yanfang Du1, Wenqu Sun2, Haiyong Wang3.   

Abstract

BACKGROUND: The study was designed to explore the value of including positive lymph node count in the TNM staging system of non-small cell lung cancer. PATIENTS AND METHODS: The X-tile model was applied to determine the cutoff values of positive lymph node count. Survival curves were generated using the Kaplan-Meier method and differences in survival among subgroups were examined using the log-rank test. The influence of different variables on overall survival and lung cancer-specific survival was further evaluated using univariate and multivariate Cox proportional hazard models. All statistical analyses were performed using SPSS version 22.0 (SPSS, Chicago, IL, USA). All p values were 2-sided and p < 0.05 was considered statistically significant.
RESULTS: The overall survival and lung cancer-specific survival between stage IIIA and IIIB classified by the sixth edition TNM staging system show no statistically significant difference (p = 0.479 for overall survival; p = 0.081 for lung cancer specific survival). The X-tile model was used to screen three different cutoff values including nN = 0, nN1-3 and nN4-. The nN value is a significant independent prognostic factor that affects overall survival and lung cancer-specific survival of non-small cell lung cancer patients (all, p < 0.001). We obtained the hypothesized TNM sub-stages based on location and the number of PLN. There were significant differences between the hypothesized stage IIIA and IIIB regarding overall survival and lung cancer-specific survival (all, p < 0.001).
CONCLUSIONS: It needs to be considered that N stage in combination with positive lymph node count may be used to predict the prognosis of non-small cell lung cancer for stage III cases with increased accuracy than category location-based stage.

Entities:  

Keywords:  Lymph node; Non-small cell lung cancer; Prognosis; Stage; Tumor-node-metastasis

Mesh:

Year:  2019        PMID: 31183778     DOI: 10.1007/s10147-019-01483-1

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  4 in total

1.  ATM gene polymorphisms are associated with poor prognosis of non-small cell lung cancer receiving radiation therapy.

Authors:  Junjun Mou; Tao Hu; Zhiwu Wang; Wei Chen; Yang Wang; Wei Zhang
Journal:  Aging (Albany NY)       Date:  2020-04-24       Impact factor: 5.682

2.  [Correlation between Lymph Node Ratio and Clinicopathological Features and Prognosis of IIIa-N2 Non-small Cell Lung Cancer].

Authors:  Shanyuan Zhang; Liang Wang; Fangliang Lu; Yuquan Pei; Yue Yang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2019-11-20

3.  Incorporating the Number of PLN into the AJCC Stage Could Better Predict the Survival for Patients with NSCLC: A Large Population-Based Study.

Authors:  Xiaoling Shang; Zhenxiang Li; Jiamao Lin; Haining Yu; Chenglong Zhao; Haiyong Wang; Jian Sun
Journal:  J Oncol       Date:  2020-12-11       Impact factor: 4.375

4.  The prognostic value of lymph node ratio in comparison to positive lymph node count in penile squamous cell carcinoma.

Authors:  Jiajie Yu; Qian Long; Zhiqiang Zhang; Shufen Liao; Fufu Zheng
Journal:  Int Urol Nephrol       Date:  2021-09-28       Impact factor: 2.370

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.